Jump to content

Bundesverband der Pharmazeutischen Industrie

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by InternetArchiveBot (talk | contribs) at 11:22, 9 July 2020 (Rescuing 1 sources and tagging 0 as dead.) #IABot (v2.0.1). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Bundesverband der Pharmazeutischen Industrie e.V.
Founded1951
Typeregistered society
FocusPolitical advocacy for the pharmaceutical industry
Location
Area served
national and international
Members
around 250 drug companies (2017)[1]
Key people
Martin Zentgraf[2]
Employees78,000 (2017)[3]
Websitewww.bpi.de

The Bundesverband der Pharmazeutischen Industrie (BPI) founded after WWII with headquarters in Berlin is a German Non-profit association and trade group for Small and medium-sized enterprises in the pharmaceutical industry. As of 2017 it represented 250 classic pharmaceutical companies, pharmaceutical service providers, biotech companies, herbal medicines and homeopathy/anthroposophy[4] with altogether approximately 78,000 employees. BPI´s focus has been on political consulting and public relations on the EU-level in order to enhance development in the national and international health care systems.

History

The Bundesverband der Pharmazeutischen Industrie (BPI) was founded after WWII with headquarters in Berlin as an Eingetragener Verein. It is the German industry association or trade group for a broad spectrum of companies in the pharmaceutical industry.[citation needed] BPI works

Large pharmaceutical companies in Germany are represented by the Verband Forschender Arzneimittelhersteller ("Association of Research-Based Pharmaceutical Companies", vfa).[5]

Another pharmaceutical industry association in Germany, the Bundesverband der Arzneimittelhersteller ("German Medicines Manufacturers' Association", BAH), has about 450 company members including 150 traditional pharmaceutical manufacturers and about 150 other members with a business interest in healthcare, such as publishers and polling organizations.[6]

The philosophy of BPI begins with the health of man and works towards enhancing the health care system to become more future-oriented. The company works towards this goal by aiding and consulting in several aspects of pharmaceutical and medical device development and improving market chances.

Function

BPI´s focus has been on political consulting and public relations on the EU-level.[7] BPI headquarters is located in Berlin. There is also an office in Brussels.

Members

As of 2017, the BPI represented about 250 German Large to medium to small pharmaceutical companies and biotech companies with altogether about 78,000 employees.[9][8]

Controversies

In 2008, the BPI was found to run a portal claiming to represent self-help support groups, while it propagated pharma industry interests.[31]

In 2010, the BPI and the vfa were listed as the most powerful lobby groups for the pharma sector in Germany.[32]

See also

References

  1. ^ "BPI: Startseite". www.bpi.de.
  2. ^ "BPI - Partner im Gesundheitswesen: Neue BPI-Führung: Dr. Martin Zentgraf als Vorstandsvorsitzender bestätigt". Bpi.de. Retrieved 5 July 2017.
  3. ^ "BPI: Startseite". www.bpi.de.
  4. ^ "BPI - Partner im Gesundheitswesen: Portrait". www.bpi.de (in German). Retrieved 2017-09-15.
  5. ^ About us & Member Companies Archived 2016-06-23 at the Wayback Machine Association of Research-Based Pharmaceutical Companies (vfa), retrieved 5 July 2017
  6. ^ Bundesverband der Arzneimittelhersteller German Medicines Manufacturers' Association, in English, accessed 4 July 2017
  7. ^ "BPI - Partner im Gesundheitswesen: BPI-Europa-Repräsentanz". Bpi.de. Retrieved 5 July 2017.
  8. ^ a b "BPI - Partner im Gesundheitswesen: Portrait". Bpi.de. Retrieved 5 July 2017.
  9. ^ a b "BPI - Partner im Gesundheitswesen: Mitgliederkarte". Bpi.de. Archived from the original on 4 August 2016. Retrieved 5 July 2017.
  10. ^ "Dental Supplies and Products - 3M ESPE Dentalprodukte - 3M Deutschland". Espe.de. Retrieved 5 July 2017.
  11. ^ "Æterna Zentaris". Aezsinc.com. 2017-05-09. Retrieved 2017-07-06.
  12. ^ "Amicus Therapeutics: Advancing Therapies to Treat Rare Diseases". Amicusrx.com. Retrieved 5 July 2017.
  13. ^ "B. Braun Sharing Expertise". Bbraun.de. Retrieved 5 July 2017.
  14. ^ "Baker McKenzie". Bakermckenzie.com. Retrieved 5 July 2017.
  15. ^ "Camurus - Leading innovation". Camurus.com. Archived from the original on 5 May 2017. Retrieved 5 July 2017.
  16. ^ "Celgene: A Global Biopharmaceutical Company Committed to Improving the Lives of Patients Worldwide with Innovative and Life-Changing Treatments". Celgene. Retrieved 5 July 2017.
  17. ^ "Startseite Fraunhofer-Gesellschaft". Fraunhofer.de. Retrieved 5 July 2017.
  18. ^ "Homepage - Fresenius SE & Co. KGaA". Retrieved 5 July 2017.
  19. ^ "Gilead Sciences, Inc". Gilead.com. Retrieved 5 July 2017.
  20. ^ "Guerbet Deutschland". Guerbet.de. Retrieved 5 July 2017.
  21. ^ "Innovative Therapies for Life - Horizon Pharma". Horizon Pharma. Retrieved 5 July 2017.
  22. ^ "Home | LEO Pharma". Leopharma.de. 2016-10-13. Retrieved 2017-07-06.
  23. ^ "Miltenyi Biotec - Biomedical instruments, reagents, and services". Miltenyibiotec.de. Retrieved 5 July 2017.
  24. ^ "mitsubishi-pharma.de". Mitsubishi-pharma.de. Retrieved 5 July 2017.
  25. ^ "Home - Northwest Biotherapeutics". Northwest Biotherapeutics. Retrieved 5 July 2017.
  26. ^ "Novartis Deutschland". Novartis.de. Retrieved 5 July 2017.
  27. ^ "Orion". Orionpharma.com. Retrieved 5 July 2017.
  28. ^ "Shionogi". Shionogi.eu. Retrieved 5 July 2017.
  29. ^ "Stallergenes - Spezialist für die Behandlung von Allergien". Stallergenes.de. Retrieved 5 July 2017.
  30. ^ "ZambonGroup - Home Page". Zambongroup.com. Retrieved 5 July 2017.
  31. ^ "Lobbyarbeit: Pharmasponsoring von Selbsthilfegruppen - Startseite - SWR odysso". swr.online (in German). 2008-03-13. Retrieved 2017-06-21.
  32. ^ "Tabelle: Die mächtigsten deutschen Lobbyorganisationen im Überblick". manager magazin (in German). 2010-07-19. Retrieved 2017-06-21.